UNVERIFIEDSingle SourceSTAT+: ARPA-H funds biotechs working on custom RNA therapiesStat News|9/2/2026
UNVERIFIEDSingle SourceSTAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costsStat News|9/2/2026
UNVERIFIEDSingle SourceSTAT+: 5 burning questions on Trump’s latest deals with drugmakersStat News|9/1/2026
UNVERIFIEDSingle SourceSTAT+: Novartis gets multiple sclerosis win with BTK inhibitorStat News|9/1/2026
UNVERIFIEDSingle SourceSTAT+: Can a pregnancy hormone steer a cardiovascular treatment? Stat News|8/31/2026
UNVERIFIEDSingle SourceSTAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watchingStat News|8/28/2026